About US
Contact us
-
U.S. indictment says Chinese hackers tried to steal COVID-19 vaccine and drug researchOnly days after three governments said Russian hackers were targeting groups conducting COVID-19 vaccine research, the U.S. hasindictedtwo Chinese nationals for hacking hundreds of companies, governm2020/7/21
-
Pandemic hits Novartis sales with eye meds, Cosentyx suffering from slowdownStockpiling of medicines boosted Novartis’ sales during the early days of COVID-19, but a hangover followed. Lagging eye drugs, slower psoriasis sales and more dragged the Swiss drugmaker's sales dow2020/7/20
-
We're looking for 2020's Fiercest Women in Life SciencesGlaxoSmithKline chief Emma Walmsley finally has some company. Three years after she became the first woman to run a Big Pharma company, she was joined by Vertex’s new CEO, Reshma Kewalramani, M.D., w2020/7/20
-
Novartis promises zero profit for 15 symptomatic COVID-19 drugs in low-income countriesNovartis’ generic hydroxychloroquine may have little use in COVID-19, but the Swiss pharma still wants to contribute its low-cost drugs in some way in the current fight. Novartis’ Sandoz unit willoff2020/7/17
-
AstraZeneca's Brilinta looks for label boost with trial win, priority review in stroke patientsBritish drugmaker AstraZeneca has placed a lot of faith—and money—in its wide-ranging R&D program for aging blood thinner Brilinta in hopes of major label expansions. So far, those results have b2020/7/17
-
Little-known Chinese firm builds $79M COVID-19 vaccine plant, eyes production next yearNo animal data, no wordon the timeline for a clinical trial, yet one little-known Chinese company is already building a multimillion-dollar facility for a COVID-19 vaccine candidate. On Saturday, Chi2020/7/16
-
Moderna has started turning out COVID-19 vaccine doses for quick shipment if approved: CEOModerna and its partners in the federal government are just now gearing up for a late-stage COVID-19 vaccine trial set to launch later this month, but at the same time, the mRNA biotech is prepping a2020/7/16
-
Gilead's remdesivir rescued from 'scrapheap' by taxpayers, who deserve a better price: lawmakerGilead Science’s remdesivir is on the very short list of drugs that have posted positive data in COVID-19, but now one U.S. lawmaker argues the company priced the medicine too high. Taxpayers spent n2020/7/15
-
Merck KGaA's manufacturing group could see billions from COVID-19 work: analystCOVID-19 vaccines are moving forward at record speeds, but market watchers have cautioned about the looming manufacturing challenges.Merck KGaA, with its manufacturing services outfit,could see billi2020/7/15
-
J&J's Tremfya grabs psoriatic arthritis nod, setting up a battle with Cosentyx, Taltz and moreJohnson & Johnson is battling giants in the immunology field with itsIL-23 inhibitorTremfya. With other next-gen drugs already crowding the market, J&J now has the FDA's nod to take Tremfya i2020/7/14